OvaScience Lands $37,000,000 Series B Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=eabfd0c9-1c20-4a95-9cc8-4fc56eaf4d63&Preview=1 - Date
4/4/2012 - Company Name
OvaScience - Mailing Address
800 Boylston Street Boston, MA 02199 - Company Description
The company is applying innovative science to improve the quality of eggs (oocytes) and increase the success of in vitro fertilization (IVF). OvaScience’s proprietary technology, exclusively licensed from Harvard Medical School and Massachusetts General Hospital, enables the use of a women’s own cellular energy to improve egg quality. - Website
http://www.ovascience.com - Transaction Type
Venture Equity - Transaction Amount
$37,000,000 - Transaction Round
Series B - Proceeds Purposes
OvaScience plans to use the proceeds from the financing to support the development and commercialization of its fertility treatment approaches based on the egg precursor cell discoveries of OvaScience co-founder Jonathan Tilly, Ph.D. - M&A Terms
- Venture Investor
General Catalyst Partners - Venture Investor
Bessemer Venture Partners - Venture Investor
Longwood Founders Fund - Venture Investor
BBT Fund - Venture Investor
Cycad Group - Venture Investor
Undisclosed
